Matrix Metalloproteinases 1 and 3 in Ovarian Cancer: Diagnostic and Prognostic Potential of Genetic Variants and Expression Profiling
<b>Background:</b> Ovarian carcinoma (OC) is one of the foremost factors in female carcinoma-related fatalities worldwide. Matrix metalloproteinases (<i>MMPs</i>) are key mediators of tissue remodeling and are linked to tumor aggressiveness, yet there is still a lack of infor...
Saved in:
| Main Authors: | Amal Mohamad Husein Mackawy, Hajed Obaid Alharbi, Ahmad Almatroudi, Wanian M. Alwanian, Khaled S. Allemailem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/12/1521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01) -
Molecular mavericks: unveiling the matrix metalloproteinase gene’s role in ovarian cancer
by: Devi Krishna Ratnakaran Bindhu, et al.
Published: (2025-04-01) -
Role of matrix metalloproteinase 7 in ovarian cancer (review of literature)
by: R. I. Knyazev, et al.
Published: (2015-09-01) -
Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01) -
The concentration of matrix metalloproteinase 9 in the tumor and peritumoral tissue as prognostic marker in breast cancer patients
by: Cvetković Danijela M., et al.
Published: (2019-01-01)